ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Faculty Opinions recommendation of Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1087568.540634
◽
2007
◽
Author(s):
Robert Sapolsky
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Phase I
◽
Phase I Trial
◽
Open Label
◽
Adeno Associated Virus
◽
Open Label Phase
Download Full-text
Related Documents
Cited By
References
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
The Lancet
◽
10.1016/s0140-6736(07)60982-9
◽
2007
◽
Vol 369
(9579)
◽
pp. 2097-2105
◽
Cited By ~ 696
Author(s):
Michael G Kaplitt
◽
Andrew Feigin
◽
Chengke Tang
◽
Helen L Fitzsimons
◽
Paul Mattis
◽
...
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Phase I
◽
Phase I Trial
◽
Open Label
◽
Adeno Associated Virus
◽
Open Label Phase
Download Full-text
Faculty Opinions recommendation of Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1087568.543850
◽
2007
◽
Author(s):
Nanna Finnerup
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Phase I
◽
Phase I Trial
◽
Open Label
◽
Adeno Associated Virus
◽
Open Label Phase
Download Full-text
429. Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease: Results from an Open-Label, Phase I Trial
Molecular Therapy
◽
10.1016/s1525-0016(16)38787-1
◽
2009
◽
Vol 17
◽
pp. S168
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Amino Acid
◽
Phase I
◽
Phase I Trial
◽
Acid Decarboxylase
◽
Open Label
◽
Amino Acid Decarboxylase
◽
Open Label Phase
Download Full-text
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
The Lancet Neurology
◽
10.1016/s1474-4422(08)70065-6
◽
2008
◽
Vol 7
(5)
◽
pp. 400-408
◽
Cited By ~ 367
Author(s):
William J Marks
◽
Jill L Ostrem
◽
Leonard Verhagen
◽
Philip A Starr
◽
Paul S Larson
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Phase I
◽
Phase I Trial
◽
Idiopathic Parkinson’S Disease
◽
Open Label
◽
Adeno Associated Virus
◽
Idiopathic Parkinson's Disease
◽
Virus Serotype
◽
Open Label Phase
Download Full-text
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
The Lancet
◽
10.1016/s0140-6736(13)61939-x
◽
2014
◽
Vol 383
(9923)
◽
pp. 1138-1146
◽
Cited By ~ 247
Author(s):
Stéphane Palfi
◽
Jean Marc Gurruchaga
◽
G Scott Ralph
◽
Helene Lepetit
◽
Sonia Lavisse
◽
...
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Dose Escalation
◽
Lentiviral Vector
◽
Phase 1
◽
Open Label
◽
Open Label Phase
Download Full-text
Faculty Opinions recommendation of Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718235629.793491568
◽
2014
◽
Author(s):
Joseph Jankovic
◽
Mary Ann Thenganatt
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Dose Escalation
◽
Lentiviral Vector
◽
Phase 1
◽
Open Label
◽
Open Label Phase
Download Full-text
Faculty Opinions recommendation of Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718318264.793494245
◽
2014
◽
Author(s):
Joanne Kurtzberg
◽
Jessica Sun
Keyword(s):
Bone Marrow
◽
Cerebral Palsy
◽
Phase I
◽
Phase I Trial
◽
Autologous Bone Marrow
◽
Open Label
◽
Children With Cerebral Palsy
◽
Open Label Phase
◽
Autologous Bone
Download Full-text
An open-label, phase I trial of transplantation therapy with allogeneic adipose tissue-derived multilineage progenitor cells in homozygous familial hypercholesterolemia patients
Atherosclerosis
◽
10.1016/j.atherosclerosis.2015.04.389
◽
2015
◽
Vol 241
(1)
◽
pp. e111
Author(s):
M. Koseki
◽
S. Yamashita
Keyword(s):
Adipose Tissue
◽
Phase I
◽
Progenitor Cells
◽
Familial Hypercholesterolemia
◽
Phase I Trial
◽
Homozygous Familial Hypercholesterolemia
◽
Open Label
◽
Open Label Phase
◽
Transplantation Therapy
Download Full-text
P2.205 A phase I/II clinical trial to evaluate the safety and efflcacy of ProSavin®, a gene therapy approach for Parkinson's disease
Parkinsonism & Related Disorders
◽
10.1016/s1353-8020(09)70556-5
◽
2009
◽
Vol 15
◽
pp. S145
Author(s):
B. Jarraya
◽
H. Lepetit
◽
S. Ralph
◽
S. Boulet
◽
C. Jan
◽
...
Keyword(s):
Parkinson’S Disease
◽
Clinical Trial
◽
Gene Therapy
◽
Parkinson's Disease
◽
Phase I
◽
Therapy Approach
◽
Gene Therapy Approach
Download Full-text
Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer
Investigational New Drugs
◽
10.1007/s10637-008-9182-8
◽
2008
◽
Vol 27
(3)
◽
pp. 253-261
◽
Cited By ~ 19
Author(s):
Michael Michael
◽
Peter Gibbs
◽
Robert Smith
◽
Alex Godwood
◽
Stuart Oliver
◽
...
Keyword(s):
Colorectal Cancer
◽
Phase I
◽
Phase I Trial
◽
Advanced Colorectal Cancer
◽
Open Label
◽
Open Label Phase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close